Thalidomide and thrombosis in patients with multiple myeloma

Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

Hematological oncology·2024

Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas.

British journal of haematology·2024

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

ESMO open·2022

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.

Scientific reports·2020

Cranial osteopathic treatment and stress-related effects on autonomic nervous system measured by salivary markers: A pilot study.

Journal of bodywork and movement therapies·2020

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Haematologica·2026

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Haematologica·2026

Response to Comment on: "SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia".

Haematologica·2026

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

Haematologica·2026

ATRA resistance conferred by a clustered subset of hotspot PML::RARA mutations enhancing basal repression rather than precluding transactivation.

Haematologica·2026

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Haematologica·2026

Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·2026

Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

Haematologica·2026

Rare inherited coagulation disorders and thrombosis.

Haematologica·2026

Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

Cureus·2026

Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

European journal of case reports in internal medicine·2026

Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

Frontiers in medicine·2026

Related Experiment Videos

Thalidomide and thrombosis in patients with multiple myeloma

Related Concept Videos

Direct determination of chronic myeloid leukemia prevalence in Lombardy-Italy: Global implications.

Prognostic impact of pretreatment cell-free DNA concentration in newly diagnosed peripheral T-cell lymphomas.

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial.

Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus.

Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.

Cranial osteopathic treatment and stress-related effects on autonomic nervous system measured by salivary markers: A pilot study.

Response to Comment on: "Mmrn1 expression defines a novel subset of hematopoietic stem cells and leukemia stem cells with great self-renewal potential".

Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap.

Response to Comment on: "SLC25A1 reprograms mitochondrial and fatty acid metabolism to promote the progression of acute myeloid leukemia".

Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy.

ATRA resistance conferred by a clustered subset of hotspot PML::RARA mutations enhancing basal repression rather than precluding transactivation.

Prognostic relevance of RUNX1 mutations at acute myeloid leukemia diagnosis and as measurable residual disease marker before and after allogeneic stem cell transplantation.

Living With Acquired Haemophilia: Patients' and Relatives' Experiences - A Single-Centre Study.

Acute heparin-induced thrombocytopenia following aortic dissection repair with platelet count recovery and anti-platelet factor 4/heparin antibody seroreversion despite ongoing device-related heparin exposure.

Rare inherited coagulation disorders and thrombosis.

Coronary-Driven Cerebral Revascularization in Type 2a Takayasu Arteritis: A Rare Multisystem Collateral Phenotype.

Severe Secondary Haemophagocytic Lymphohistiocytosis Syndrome Due to Crimean-Congo Haemorrhagic Fever Virus: Thinking out of the Box.

Comparison of the efficacy and safety of nafamostat mesylate and heparin in blood purification therapy for patients with severe acute pancreatitis: protocol for a randomized controlled trial.

Related Experiment Videos

Thalidomide and thrombosis in patients with multiple myeloma

Related Concept Videos

Related Articles